Literature DB >> 25789599

A role of WT1 in cell division and genomic stability.

Jayasha Shandilya1, Stefan G E Roberts.   

Abstract

Wilms' tumor-1 protein (WT1) is a transcription factor that can either activate or repress genes to regulate cell growth, apoptosis and differentiation. WT1 can act as either a tumor suppressor or an oncogene. The cellular functions of WT1 are predominantly regulated by its various interacting partners. Recently we have found that WT1 can regulate the fidelity of chromosome segregation through its interaction with the spindle assembly checkpoint protein, Mitotic arrest deficient-2 (MAD2). WT1 delays anaphase entry by inhibiting the ubiquitination activity of the Anaphase promoting complex/cyclosome (APC/C). Our findings have revealed an important role of WT1 in the regulation of mitotic checkpoint and genomic stability.

Entities:  

Keywords:  Mad2; WT1; checkpoint; mitosis

Mesh:

Substances:

Year:  2015        PMID: 25789599      PMCID: PMC4614692          DOI: 10.1080/15384101.2015.1021525

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  63 in total

Review 1.  Transcriptional regulation by WT1 in development.

Authors:  Stefan G E Roberts
Journal:  Curr Opin Genet Dev       Date:  2005-10       Impact factor: 5.578

Review 2.  RB and cell cycle progression.

Authors:  C Giacinti; A Giordano
Journal:  Oncogene       Date:  2006-08-28       Impact factor: 9.867

3.  SUMO-1 modification of the Wilms' tumor suppressor WT1.

Authors:  Gromoslaw A Smolen; Maria T Vassileva; Julie Wells; Michael J Matunis; Daniel A Haber
Journal:  Cancer Res       Date:  2004-11-01       Impact factor: 12.701

Review 4.  Wilms' tumours: about tumour suppressor genes, an oncogene and a chameleon gene.

Authors:  Vicki Huff
Journal:  Nat Rev Cancer       Date:  2011-01-20       Impact factor: 60.716

5.  Phosphorylation of Activation Transcription Factor-2 at Serine 121 by Protein Kinase C Controls c-Jun-mediated Activation of Transcription.

Authors:  Takahito Yamasaki; Akinori Takahashi; Jianzhi Pan; Naoto Yamaguchi; Kazunari K Yokoyama
Journal:  J Biol Chem       Date:  2009-01-28       Impact factor: 5.157

Review 6.  The Mad1-Mad2 balancing act--a damaged spindle checkpoint in chromosome instability and cancer.

Authors:  Scott C Schuyler; Yueh-Fu Wu; Vivian Jen-Wei Kuan
Journal:  J Cell Sci       Date:  2012-10-23       Impact factor: 5.285

7.  MAD2-induced sensitization to vincristine is associated with mitotic arrest and Raf/Bcl-2 phosphorylation in nasopharyngeal carcinoma cells.

Authors:  Xianghong Wang; Dong-Yan Jin; Hing Lok Wong; Huichen Feng; Yong-Chuan Wong; Sai Wah Tsao
Journal:  Oncogene       Date:  2003-01-09       Impact factor: 9.867

Review 8.  The many facets of the Wilms' tumour gene, WT1.

Authors:  Peter Hohenstein; Nicholas D Hastie
Journal:  Hum Mol Genet       Date:  2006-10-15       Impact factor: 6.150

Review 9.  The spindle assembly checkpoint.

Authors:  Pablo Lara-Gonzalez; Frederick G Westhorpe; Stephen S Taylor
Journal:  Curr Biol       Date:  2012-11-20       Impact factor: 10.834

10.  Dynamic interaction between WT1 and BASP1 in transcriptional regulation during differentiation.

Authors:  Laura M Green; Kate J Wagner; Hayley A Campbell; Kelly Addison; Stefan G E Roberts
Journal:  Nucleic Acids Res       Date:  2008-12-02       Impact factor: 16.971

View more
  11 in total

1.  Wilms' tumor 1 drives fibroproliferation and myofibroblast transformation in severe fibrotic lung disease.

Authors:  Vishwaraj Sontake; Rajesh K Kasam; Debora Sinner; Thomas R Korfhagen; Geereddy B Reddy; Eric S White; Anil G Jegga; Satish K Madala
Journal:  JCI Insight       Date:  2018-08-23

2.  Regulation of AURORA B function by mitotic checkpoint protein MAD2.

Authors:  Jayasha Shandilya; Kathryn F Medler; Stefan G E Roberts
Journal:  Cell Cycle       Date:  2016-06-24       Impact factor: 4.534

3.  Aberrant expression of ETS1 and ETS2 proteins in cancer.

Authors:  Elizabeth A Fry; Kazushi Inoue
Journal:  Cancer Rep Rev       Date:  2018-04-23

4.  Unsupervised tensor decomposition-based method to extract candidate transcription factors as histone modification bookmarks in post-mitotic transcriptional reactivation.

Authors:  Y-H Taguchi; Turki Turki
Journal:  PLoS One       Date:  2021-05-25       Impact factor: 3.240

Review 5.  Moonlighting in Mitosis: Analysis of the Mitotic Functions of Transcription and Splicing Factors.

Authors:  Maria Patrizia Somma; Evgeniya N Andreyeva; Gera A Pavlova; Claudia Pellacani; Elisabetta Bucciarelli; Julia V Popova; Silvia Bonaccorsi; Alexey V Pindyurin; Maurizio Gatti
Journal:  Cells       Date:  2020-06-26       Impact factor: 6.600

6.  Prognostic Impact of WT-1 Gene Expression in Egyptian Children with Acute Lymphoblastic Leukemia.

Authors:  Adel A Hagag; Ibrahim M Badraia; Samir M Hassan; Amal E Abd El-Lateef
Journal:  Mediterr J Hematol Infect Dis       Date:  2016-01-01       Impact factor: 2.576

7.  Deficiency of PTEN leads to aberrant chromosome segregation through downregulation of MAD2.

Authors:  Zhuo Sun; Jinqi Lu; Muyu Wu; Mingyan Li; Lu Bai; Zhenduo Shi; Lin Hao; Yongping Wu
Journal:  Mol Med Rep       Date:  2019-09-10       Impact factor: 2.952

8.  Loss of CBX2 induces genome instability and senescence-associated chromosomal rearrangements.

Authors:  Claudia Baumann; Xiangyu Zhang; Rabindranath De La Fuente
Journal:  J Cell Biol       Date:  2020-11-02       Impact factor: 10.539

9.  Targeting MAD2 modulates stemness and tumorigenesis in human Gastric Cancer cell lines.

Authors:  Natalia Pajuelo-Lozano; Sonia Alcalá; Bruno Sainz; Rosario Perona; Isabel Sanchez-Perez
Journal:  Theranostics       Date:  2020-07-25       Impact factor: 11.556

10.  PIGN spatiotemporally regulates the spindle assembly checkpoint proteins in leukemia transformation and progression.

Authors:  Emmanuel K Teye; Shasha Lu; Fangyuan Chen; Wenrui Yang; Thomas Abraham; Douglas B Stairs; Hong-Gang Wang; Gregory S Yochum; Robert A Brodsky; Jeffrey J Pu
Journal:  Sci Rep       Date:  2021-09-24       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.